Should you buy Core Scientific stock now?
The technical signal for Core Scientific is currently NEUTRAL. Core Scientific trades at $21.46 as of 8/6/2026. The overall technical signal is: Hold. The technical analysis shows the following: MACD is negative (bearish trend) at -0.760 with rising momentum (signal: -0.917); RSI is at 46.8 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $37.13 points to 73.0% upside. This is a technical observation based on current data, not investment advice.
What is the price target for Core Scientific stock?
The average analyst price target for Core Scientific is $37.13. The current price is $21.46, which gives an upside of 73.0%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $33.42 and $40.84.
Is Core Scientific a dividend stock?
No, Core Scientific does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Core Scientific stock?
Core Scientific is rated as a stock with high risk. the annual standard deviation is 69.5%, which classifies the stock as high risk.
Is Core Scientific overvalued?
No, Core Scientific is considered undervalued based on the analyst price target (73.0% upside). Core Scientific has the following valuation ratios: a P/S ratio of 16.6. The analyst price target suggests that the stock is undervalued by 73.0%.
Is Core Scientific overbought?
No, Core Scientific is not overbought. RSI is at 46.8 (neutral zone). The technical indicators show: RSI is at 46.8 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 3.1% below the 20-day average (short-term downtrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Core Scientific earnings report?
The date of the next earnings report for Core Scientific has not been published yet. Check the company's investor calendar for updates.
Is Core Scientific shorted?
Yes, Core Scientific is shorted with 22.4% of the free float sold short. This is an extremely high level of short selling, which points to great skepticism among institutional investors. The risk of a short squeeze on positive news or earnings is very high. Data is updated daily based on official filings with the SEC.
Are insiders buying Core Scientific stock?
No, insiders are not buying Core Scientific shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 16 sales. On a net basis, 3,408,629 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 4,348,594 $ sold. Active sellers include DUCHENE TODD M, Sullivan Adam Taylor. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Core Scientific a good stock?
Based on our total score, Core Scientific is rated as a poor stock with a total score of 20 out of 100. The stock scores below average on value, quality and momentum – it sits at the lower end of the market. The score is made up of Value: 5/100, Quality: 18/100, Momentum: 37/100. In addition: analysts see 73.0% upside to the price target; technical signal: Hold. Whether Core Scientific is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Core Scientific stock?
The outlook for Core Scientific based on current data: the average analyst price target is $37.13 (+73.0%). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Core Scientific stock falling?
Core Scientific is falling right now. The technical indicators show: the price is 3.1% below the 20-day average; short interest is 22.4% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Core Scientific go?
The average analyst price target for Core Scientific is $37.13, which corresponds to a potential gain of 73.0% from the current price of $21.46. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Core Scientific fall?
We lack enough history to give a specific floor for Core Scientific. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Core Scientific do?
Core Scientific, Inc. provides net carbon-neutral blockchain infrastructure and digital asset mining solutions in North America. It operates in two segments, Equipment Sales and Hosting. It offers blockchain hosting services with deployment and provide power, racks, proprietar... The company belongs to the Teknologi sector, more specifically the Software - Infrastructure industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Core Scientific as an investment.
Did Core Scientific raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Core Scientific. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Core Scientific making money or losing money?
We have no current profitability data for Core Scientific. See the latest report in the earnings history above.
Can Core Scientific go bankrupt?
The bankruptcy risk of Core Scientific is rated as elevated. Altman Z2 (a model for assessing financial distress) is -5.99 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 2 — which is weak. Debt relative to equity is 1,000% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Core Scientific have a lot of debt?
Yes, Core Scientific has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 1,000%. For the teknologi sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
